| Metzger Michael AChief Executive Officer, Director · 62 transactions | +1384.6% | 484.8K | 1.09M | — | 625.0K |
| Podlesak DennisDirector · 18 transactions | +453.7% | 239.8K | 332.4K | — | 136.4K |
| Goldan Keith A.Chief Financial Officer · 20 transactions | — | 139.3K | 144.1K | 4.3K | 12.3K |
| Katkin KeithDirector · 22 transactions | +675% | 124.0K | 132.0K | 10.0K | 34.0K |
| Legault PierreDirector · 19 transactions | +612.5% | 114.0K | 205.0K | — | 107.0K |
| Jarrett JenniferDirector · 5 transactions | +612.5% | 114.0K | 98.0K | — | — |
| Huber Martin H. Jr.Director · 6 transactions | — | 103.0K | 98.0K | 5.0K | — |
| Meury WilliamDirector · 10 transactions | +462.5% | 90.0Kas of Feb 2025 | 157.0K | — | 83.0K |
| Gallagher NeilPresident, Head of R&D · 5 transactions | — | 85.1Kas of Feb 2025 | 89.7K | — | 4.6K |
| Botwood Nicholas A.J.Head of R&D, CMO · 7 transactions | — | 60.9K | 113.8K | 11.8K | 65.5K |
| Rizo AleksandraDirector · 2 transactions | — | 49.0K | 49.0K | — | — |
| Morrison BriggsDirector · 39 transactions | -27.9% | 34.8Kas of Feb 2024 | 1.08M | — | 991.2K |
| Egros FabriceDirector · 5 transactions | +1.2% | 32.0Kas of Feb 2022 | 30.0K | — | 14.0K |
| Meyers Michael L.SVP, Chief Medical Officer · 2 transactions | +48.6% | 23.3Kas of Jan 2022 | 5.9K | — | — |
| Ordentlich PeterChief Scientific Officer · 19 transactions | -100% | 0as of Feb 2023 | 75.0K | — | 76.5K |
| Nolte AlexanderChief Accounting Officer · 2 transactions | — | 0as of Feb 2022 | — | — | 968 |